Symphony Talent Continues Growth, Adds New Clients
Brands across all industries tap into Symphony Talent's innovative talent acquisition solutions
New York, May 01, 2018 (GLOBE NEWSWIRE) -- Symphony Talent, a leading Talent Acquisition solutions provider, today announced additions to its global client base across a diversified field of industries, demonstrating the company's continued momentum in applying its data-driven, consumer marketing approach in the HR tech and Employer Branding space through the company's Hodes, M-Cloud and X-Cloud solutions.
"Today's Talent Acquisition leaders are not only expected to attract, hire and engage the best talent but also to help drive the change management agenda in their organization's transformation," said Roopesh Nair, president and CEO, Symphony Talent. "Our strong growth trajectory is indicative of a global trend as organizations continue to recognize the need to leverage data while bringing digital and brand to the core of their operations to meet the changing expectations of the social, mobile and digital natives who are their customers, candidates and employees."
Symphony Talent's fully modular solutions (Hodes, M-Cloud and X-Cloud) go far beyond just what recruiters and candidates need, to provide what they expect in today's consumer-centric environment. By combining employer branding, recruitment marketing, award winning creative, candidate and employee engagement, and media optimization, Symphony Talent's solutions empower leading brands to redefine and modernize their talent acquisition and employee engagement efforts. The result is the delivery of personalized, relevant and captivating experiences for recruiters, candidates and employees.
The company recently added more than 20 new marquee brands to its global portfolio. These signings, the organization's expanded relationships with existing clients, and the continued solutions innovation are key drivers of Symphony Talent's successful start in 2018. Recent client additions across North America, Europe and APAC include: Bashas' Inc., Invesco, Fidelity National Information Services (FIS), Highmark Health, Compass Group Canada, Liberty Mutual, VCA, Parsons, Cambridge Consultants, Baylor, Scott & White, Regis Corporation, UCLA Health, Sonova, Orkla, Merck, Sky and Epsilon.
European Managing Director, Simon Phillips added; "It's been a hugely exciting time over the past 12-months watching our rapid growth evolve even further with the combination of award-winning creative and brand strategy being powered by game-changing technology. This is delivering incredible personalized experiences both inside and outside of the organizations we're working with and for the new clients we're winning."
"Organizations in APAC are increasingly differentiating themselves through investments in technology and award winning creative," noted Kesavan Kanchi Kandadai, Managing Director for India and APAC. "Symphony Talent recognizes that need and is excited to help organizations realize their brand promise through the power of our innovative solutions. These recent client additions serve to strengthen our commitment to invest and grow our Asia Pacific business in the next 2 years."
"Our customers are realizing significant, measurable results as they leverage our solutions to attract, hire, and engage the highest quality talent," Nair added. "I'm proud of the trust our clients invest with us, as well as our global team's commitment to innovation to ensure that our solutions are evolving with our client's and the market's needs."
About Symphony Talent
Symphony Talent is redefining how employers and talent connect. By applying data-driven consumer marketing best practices, we provide seamless, personalized experiences through our best-in-class smart technology, award winning creative, and trusted strategy and client services solutions. We simplify and streamline the process to find, hire, and engage talent. The result is a unified, seamless experience for recruiters, hiring managers, and candidates. Companies such as Northwell Health, Chili's and UnitedHealth Group rely on Symphony Talent to power their talent acquisition efforts. For more information, visit: www.symphonytalent.com or follow us on Twitter, @SymphonyTalent_.
# # #
Colleen Naugle Symphony Talent 4844592686 firstname.lastname@example.org
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Symphony Talent via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
The Graduate Management Admission Council Selects Three New Business Schools for Membership10.12.2018 16:26 | Pressemelding
Schools Bring Expertise and Insight in Support of GMAC Mission RESTON, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) -- The Graduate Management Admission Council (GMAC), a global association of leading graduate business schools, welcomes three new members. The addition of ESCP Europe, WHU – Otto Beisheim School of Management, and Xavier University Bhubaneswar brings GMAC’s total membership to 225. Select business schools are invited to apply for GMAC membership by its Board of Directors. Each school goes through a comprehensive application process that addresses the sustained commitments to supporting GMAC’s mission: providing the tools and information necessary for schools and talent to discover and evaluate each other. “GMAC continues to strengthen our membership of graduate business schools that are not only working to address the changing needs of students, but also understanding the landscape and what can be done to better prepare students for their careers,” said Sangeet Chowfla, president
Doc re. GE Files Form 8-K10.12.2018 16:08 | Pressemelding
FAIRFIELD, Conn., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Company General Electric Company ISIN US3696041033 Symbol London: GEC | Paris: GNE Headline Doc re: GE files Form 8-K December 10, 2018 On December 10, 2018, General Electric Company (the "Company") filed a Form 8-K with the U.S. Securities and Exchange Commission ("SEC"), which has been submitted to RNS. It is also available on the SEC's website at http://www.sec.gov and on the Company's website at https://www.ge.com/investor-relations/events-reports. http://www.rns-pdf.londonstockexchange.com/rns/0008K_1-2018-12-10.pdf CONTACT: GE Jennifer Erickson +001 646 682 5620 email@example.com This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visi
Robex Resources Inc.: Drilling Results Confirming and Extending Gold Mineralization at Nampala10.12.2018 15:28 | Pressemelding
QUÉBEC CITY, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Robex Resources Inc. (« Robex » and/or « the Company ») (TSXV : RBX / FWB : RB4) is pleased to provide drilling results from the ongoing drill definition and exploration program at its 100% owned Nampala gold project located in the Sikasso administrative region of the Republic of Mali. The 20,000 meters drill program commenced in September 2018. The program is currently focused on infill drilling within the Nampala open pit and resource area and on exploration drilling on the adjacent Mininko exploration permit. The Company is reporting assay results from 57 drill holes (totaling 5,392 metres): 13 diamond drill holes (totaling 1,272 meters) and 44 RC holes (totaling 4,120 meters). The program is still ongoing and other results will be reported once the results are received, validated and compiled. In this release, significant assay results from 43 intercepts in 23 drill holes are reported herein are provided in Table 1 below and include th
WillScot Announces Completion of Warrant Exchange Offer10.12.2018 15:09 | Pressemelding
BALTIMORE, Dec. 10, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the completion of its previously announced exchange offer (the “Exchange Offer”) relating to certain outstanding warrants (the “Warrants”). The Exchange Offer expired at 11:59 p.m., Eastern Time, on December 7, 2018. Under the terms of the Exchange Offer, each Warrant holder had the opportunity to receive 0.18182 shares of WillScot Class A Common Stock, par value $0.0001 per share (“Common Stock”), for each Warrant tendered by the holder and exchanged pursuant to the Exchange Offer. As of the expiration of the Exchange Offer on December 7, 2018 at 11:59 p.m. Eastern Time, 45,131,827 outstanding Warrants were properly tendered and not withdrawn in the Exchange Offer. 45,031,827 of the Warrants tendered were public warrants, representing approximatel
CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease 10.12.2018 15:00 | Pressemelding
Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, and THE NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE, a national and international center of excellence in neuroscience with its mission to improve lives through integrated clinical service, research and education, announced today that they have obtained animal proof of concept for CERESPIR’s clinical stage compound itanapraced in Parkinson’s disease models. Specifically, itanapraced, which was previously tested with positive results in patients with mild cognitive impairment (MCI), was shown to block the expression of LRRK2 and, additionally, prevent neurotoxicity resulting in the preservati
DSM Sinochem Pharmaceuticals announces its new name - Centrient Pharmaceuticals10.12.2018 13:29 | Pressemelding
The name, resulting from a change in ownership, reflects its role at the centre of modern healthcare ROTTERDAM, Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Effective December 10, 2018 Centrient Pharmaceuticals is the new name for DSM Sinochem Pharmaceuticals, the leading manufacturer of beta-lactam antibiotics and a provider of next-generation statins and anti-fungals . The new name has been chosen to reflect the company’s key contribution to modern healthcare, and marks the next phase in its strategic evolution following a change of ownership to Bain Capital Private Equity. CEO Karl Rotthier states: “Our bold and creative new name and logo showcase our company as one which prides itself on being at the centre of modern healthcare, through our life-saving active pharmaceutical ingredients and finished dosage forms. We’re building on a rich history that began 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, then Gist Brocades and more recently DSM Sinochem Pharmaceutica
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom